To support the role of BRCA2 expression for olaparib sensitivity in colorectal cancer, we first detected the IC50 of olaparib in three different colorectal cancer cell lines: HCT116, HCT15, and SW480 (Figure 1A). Here, BRCA2 is linked to colorectal cancer.